American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards
Overview
Authors
Affiliations
Standardization of care can reduce the risk of errors, increase efficiency, and provide a framework for best practice. In 2008, the American Society of Clinical Oncology (ASCO) and the Oncology Nursing Society (ONS) invited a broad range of stakeholders to create a set of standards for the administration of chemotherapy to adult patients in the outpatient setting. At the close of a full-day structured workshop, 64 draft standards were proposed. After a formal process of electronic voting and conference calls, 29 draft standards were eliminated, resulting in a final list of 35 draft measures. The proposed set of standards was posted for 6 weeks of open public comment. Three hundred twenty-two comments were reviewed by the Steering Group and used as the basis for final editing to a final set of standards. The final list includes 31 standards encompassing seven domains, which include the following: review of clinical information and selection of a treatment regimen; treatment planning and informed consent; ordering of treatment; drug preparation; assessment of treatment compliance; administration and monitoring; assessment of response and toxicity monitoring. Adherence to ASCO and ONS standards for safe chemotherapy administration should be a goal of all providers of adult cancer care.
Abdus-Salam A, Ntekim A, Folorunso S, Folasire A, Jimoh M, Adenipekun A Niger Med J. 2024; 62(4):202-207.
PMID: 38694219 PMC: 11058440. DOI: 10.60787/NMJ-62-4-37.
Evaluation of an Interprofessional Training Program to Improve Cancer Drug Therapy Safety.
Aebersold M, Kraft S, Farris K, Scherdt M, Olsen M, Polovich M JCO Oncol Pract. 2021; 17(10):e1551-e1558.
PMID: 33577351 PMC: 9810130. DOI: 10.1200/OP.20.00816.
Santo L, Ward B, Rui P, Ashman J Cancer Causes Control. 2020; 31(4):353-363.
PMID: 32086673 PMC: 7448541. DOI: 10.1007/s10552-020-01281-5.
Zimmer J, Niemann D, Seltmann K, Fischer L, Christiansen H, Frontini R Eur J Hosp Pharm. 2019; 23(2):100-105.
PMID: 31156825 PMC: 6451606. DOI: 10.1136/ejhpharm-2015-000716.
Vera R, Otero M, de la Pena F, Gonzalez-Perez C, Penuelas A, Sepulveda J Clin Transl Oncol. 2018; 21(4):467-478.
PMID: 30298467 DOI: 10.1007/s12094-018-1945-x.